Zhao et al. developed a new technique for detecting cancer stem cell biomarkers (CSCs), CD44 for breast cancer, with LOD’s of 2.17 pg/mL and 8 cells/mL, for CD44 and CD44-positive CSC respectively [70]. Here, CD44 is linked to breast cancer.